Yue; Eddy W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yue; Eddy W..The latest application filed is for "spirocyclic lactams as jak2 v617f inhibitors".

Company Profile

23.62.68

Yue; Eddy W. - Landenberg PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Spirocyclic Lactams As Jak2 V617f Inhibitors App 20220281887 - Shepard; Stacey ; et al.	2022-09-08
Heterocyclylamines as PI3K inhibitors Grant 11,433,071 - Li , et al. September 6, 2	2022-09-06
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20220251087 - Buesking; Andrew W. ; et al.	2022-08-11
TERTIARY ALCOHOLS AS PI3K-y INHIBITORS App 20220213107 - Douty; Brent ; et al.	2022-07-07
Tricyclic Urea Compounds As Jak2 V617f Inhibitors App 20220169649 - Ai; Yanran ; et al.	2022-06-02
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20220119393 - Li; Yun-Long ; et al.	2022-04-21
Crystalline Forms Of A Phosphoinositide 3-kinase (pi3k) Inhibitor App 20220112198 - Douty; Brent ; et al.	2022-04-14
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20220106318 - Li; Yun-Long ; et al.	2022-04-07
Tricyclic Urea Compounds As Jak2 V617f Inhibitors App 20220064165 - Liu; Kai ; et al.	2022-03-03
Tertiary alcohols as PI3K-.gamma. inhibitors Grant 11,225,486 - Douty , et al. January 18, 2	2022-01-18
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Grant 11,207,302 - Combs , et al. December 28, 2	2021-12-28
Modulators of indoleamine 2,3-dioxygenase and methods of using the same Grant 11,192,868 - Combs , et al. December 7, 2	2021-12-07
Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor Grant 11,186,580 - Douty , et al. November 30, 2	2021-11-30
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20210332059 - Li; Yun-Long ; et al.	2021-10-28
Heterocyclic compounds as PI3K-y inhibitors Grant 11,091,491 - Shvartsbart , et al. August 17, 2	2021-08-17
Aminopyrazine derivatives as PI3K-.gamma. inhibitors Grant 11,046,658 - Douty , et al. June 29, 2	2021-06-29
Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors Grant 10,975,088 - Buesking , et al. April 13, 2	2021-04-13
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase App 20210030722 - Combs; Andrew P. ; et al.	2021-02-04
TERTIARY ALCOHOLS AS PI3K-y INHIBITORS App 20200385392 - Douty; Brent ; et al.	2020-12-10
Heterocyclylamines As Pi3k Inhibitors App 20200323858 - Li; Yun-Long ; et al.	2020-10-15
Tertiary alcohols as PI3K-.gamma. inhibitors Grant 10,738,057 - Douty , et al. A	2020-08-11
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Grant 10,653,677 - Combs , et al.	2020-05-19
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20200102315 - Buesking; Andrew W. ; et al.	2020-04-02
Crystalline Forms Of A Phosphoinositide 3-kinase (pi3k) Inhibitor App 20200071335 - Douty; Brent ; et al.	2020-03-05
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20200031837 - Shvartsbart; Artem ; et al.	2020-01-30
AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS App 20200002295 - Douty; Brent ; et al.	2020-01-02
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors Grant 10,479,795 - Buesking , et al. Nov	2019-11-19
Heterocyclic compounds as PI3K-.gamma. inhibitors Grant 10,472,368 - Shvartsbart , et al. Nov	2019-11-12
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase App 20190298700 - Combs; Andrew P. ; et al.	2019-10-03
Heterocyclylamines As Pi3k Inhibitors App 20190298724 - Sparks; Richard B. ; et al.	2019-10-03
Heterocyclylamines as PI3K inhibitors Grant 10,376,513 - Sparks , et al. A	2019-08-13
1,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Grant 10,369,137 - Combs , et al.	2019-08-06
Modulators Of Indoleamine 2,3-dioxygenase And Methods Of Using The Same App 20190210985 - Combs; Andrew P. ; et al.	2019-07-11
TERTIARY ALCOHOLS AS PI3K-y INHIBITORS App 20190152975 - Douty; Brent ; et al.	2019-05-23
Heterocyclylamines As Pi3k Inhibitors App 20190134040 - Li; Yun-Long ; et al.	2019-05-09
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20190119287 - Buesking; Andrew W. ; et al.	2019-04-25
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20190062336 - Shvartsbart; Artem ; et al.	2019-02-28
Modulators of indoleamine 2,3-dioxygenase and methods of using the same Grant 10,208,002 - Combs , et al. Feb	2019-02-19
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20190040067 - Li; Yun-Long ; et al.	2019-02-07
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-.gamma. inhibitors Grant 10,138,248 - Buesking , et al. Nov	2018-11-27
Heterocyclylamines as PI3K inhibitors Grant 10,092,570 - Li , et al. October 9, 2	2018-10-09
Heterocyclic compounds as PI3K-.gamma. inhibitors Grant 10,065,963 - Shvartsbart , et al. September 4, 2	2018-09-04
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Grant 10,034,864 - Combs , et al. July 31, 2	2018-07-31
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase App 20180177769 - Combs; Andrew P. ; et al.	2018-06-28
Use of pyrazolopyrimidine derivatives for the treatment of PI3K-delta related disorders Grant 9,932,341 - Li , et al. April 3, 2	2018-04-03
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors Grant 9,918,990 - Yue , et al. March 20, 2	2018-03-20
Modulators Of Indoleamine 2,3-dioxygenase And Methods Of Using The Same App 20180030006 - Combs; Andrew P. ; et al.	2018-02-01
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20180009816 - Buesking; Andrew W. ; et al.	2018-01-11
Tricyclic heterocycles as BET protein inhibitors Grant 9,850,257 - Combs , et al. December 26, 2	2017-12-26
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase App 20170348289 - Combs; Andrew P. ; et al.	2017-12-07
Heterocyclylamines As Pi3k Inhibitors App 20170340641 - Li; Yun-Long ; et al.	2017-11-30
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors Grant 9,815,839 - Li , et al. November 14, 2	2017-11-14
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Grant 9,789,094 - Combs , et al. October 17, 2	2017-10-17
Bicyclic heterocycles as bet protein inhibitors Grant 9,737,516 - Yue , et al. August 22, 2	2017-08-22
Heterocyclylamines as PI3K inhibitors Grant 9,730,939 - Li , et al. August 15, 2	2017-08-15
Tricyclic Heterocycles As Bet Protein Inhibitors App 20170217985 - Combs; Andrew P. ; et al.	2017-08-03
Heterocyclylamines as PI3K inhibitors Grant 9,707,233 - Li , et al. July 18, 2	2017-07-18
N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines As Pi3k Inhibitors App 20170158696 - Li; Yun-Long ; et al.	2017-06-08
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20170129899 - Shvartsbart; Artem ; et al.	2017-05-11
Bicyclic Heterocycles As Bet Protein Inhibitors App 20170014418 - Yue; Eddy W. ; et al.	2017-01-19
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors Grant 9,527,848 - Li , et al. December 27, 2	2016-12-27
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase App 20160220543 - Combs; Andrew P. ; et al.	2016-08-04
Substituted heteroaryl fused derivatives as P13K inhibitors Grant 9,403,847 - Combs , et al. August 2, 2	2016-08-02
Bicyclic Heterocycles As Bet Protein Inhibitors App 20160213654 - Yue; Eddy W. ; et al.	2016-07-28
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors Grant 9,399,640 - Yue , et al. July 26, 2	2016-07-26
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Grant 9,320,732 - Combs , et al. April 26, 2	2016-04-26
Bicyclic heterocycles as BET protein inhibitors Grant 9,315,501 - Yue , et al. April 19, 2	2016-04-19
Tricyclic heterocycles as BET protein inhibitors Grant 9,290,514 - Combs , et al. March 22, 2	2016-03-22
Heterocyclylamines As Pi3k Inhibitors App 20160024117 - Li; Yun-Long ; et al.	2016-01-28
Heterocyclylamines As Pi3k Inhibitors App 20160022685 - Li; Yun-Long ; et al.	2016-01-28
Heterocyclylamines as PI3K inhibitors Grant 9,199,982 - Li , et al. December 1, 2	2015-12-01
Fused derivatives as PI3K.delta. inhibitors Grant 9,193,721 - Combs , et al. November 24, 2	2015-11-24
N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines As Pi3k Inhibitors App 20150284390 - Li; Yun-Long ; et al.	2015-10-08
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors Grant 9,126,948 - Combs , et al. September 8, 2	2015-09-08
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors Grant 9,108,984 - Combs , et al. August 18, 2	2015-08-18
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors Grant 9,096,600 - Li , et al. August 4, 2	2015-08-04
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase App 20150190378 - Combs; Andrew P. ; et al.	2015-07-09
Bicyclic Heterocycles As Bet Protein Inhibitors App 20150148372 - Yue; Eddy W. ; et al.	2015-05-28
Bicyclic Heterocycles As Bet Protein Inhibitors App 20150148342 - Yue; Eddy W. ; et al.	2015-05-28
Bicyclic Heterocycles As Bet Protein Inhibitors App 20150148375 - Yue; Eddy W. ; et al.	2015-05-28
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Grant 8,993,605 - Combs , et al. March 31, 2	2015-03-31
Tricyclic Heterocycles As Bet Protein Inhibitors App 20150011540 - Combs; Andrew P. ; et al.	2015-01-08
Modulators Of Indoleamine 2,3-dioxygenase And Methods Of Using The Same App 20140377292 - Combs; Andrew P. ; et al.	2014-12-25
Macrocyclic compounds and their use as kinase inhibitors Grant 8,871,753 - Combs , et al. October 28, 2	2014-10-28
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase App 20140315962 - Combs; Andrew P. ; et al.	2014-10-23
Modulators of indoleamine 2,3-dioxygenase and methods of using the same Grant 8,846,726 - Combs , et al. September 30, 2	2014-09-30
Substituted Heteroaryl Fused Derivatives As Pi3k Inhibitors App 20140275127 - Combs; Andrew P. ; et al.	2014-09-18
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20140249132 - Li; Yun-Long ; et al.	2014-09-04
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Grant 8,822,511 - Combs , et al. September 2, 2	2014-09-02
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Grant 8,796,319 - Combs , et al. August 5, 2	2014-08-05
Substituted heteroaryl fused derivatives as PI3K inhibitors Grant 8,759,359 - Combs , et al. June 24, 2	2014-06-24
Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors Grant 8,680,108 - Li , et al. March 25, 2	2014-03-25
Substituted Diamino-pyrimidine And Diamino-pyridine Derivatives As Pi3k Inhibitors App 20140066448 - Combs; Andrew P. ; et al.	2014-03-06
Pyrimidine-4,6-diamine Derivatives As Pi3k Inhibitors App 20140057912 - Combs; Andrew P. ; et al.	2014-02-27
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3-Dioxygenase App 20140023663 - Combs; Andrew P. ; et al.	2014-01-23
Modulators Of Indoleamine 2,3-dioxygenase And Methods Of Using The Same App 20130123246 - Combs; Andrew P. ; et al.	2013-05-16
Heterocyclylamines As Pi3k Inhibitors App 20130059835 - Li; Yun-Long ; et al.	2013-03-07
Modulators of indoleamine 2,3-dioxygenase and methods of using the same for treating cancer Grant 8,372,870 - Combs , et al. February 12, 2	2013-02-12
N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines As Pi3k Inhibitors App 20120157430 - Li; Yun-Long ; et al.	2012-06-21
1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase App 20120058079 - Combs; Andrew P. ; et al.	2012-03-08
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Grant 8,088,803 - Combs , et al. January 3, 2	2012-01-03
Modulators Of Indoleamine 2,3-dioxygenase And Methods Of Using The Same App 20110311479 - Combs; Andrew P. ; et al.	2011-12-22
Fused Derivatives As Pi3kdelta Inhibitors App 20110281884 - Combs; Andrew P. ; et al.	2011-11-17
Modulators of indoleamine 2,3-dioxygenase and methods of using the same Grant 8,034,953 - Combs , et al. October 11, 2	2011-10-11
Substituted Heteroaryl Fused Derivatives As Pi3k Inhibitors App 20110190319 - Combs; Andrew P. ; et al.	2011-08-04
Substituted Fused Aryl And Heteroaryl Derivatives As Pi3k Inhibitors App 20110183985 - Li; Yun-Long ; et al.	2011-07-28
1,2,5-oxadiazoles As Inhibitors Of Indoleamine 2,3-dioxygenase App 20100015178 - Combs; Andrew P. ; et al.	2010-01-21
Macrocyclic Compounds And Their Use As Kinase Inhibitors App 20090286778 - Combs; Andrew Paul ; et al.	2009-11-19
Modulators of indoleamine 2,3-dioxygenase and methods of using the same App 20060258719 - Combs; Andrew P. ; et al.	2006-11-16
Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use Grant 6,844,318 - Copeland , et al. January 18, 2	2005-01-18
3-(2,4-dimethylthiazol-5-yl)indeno[1,2-c]pyrazol-4-one derivatives and their uses Grant 6,706,718 - Yue March 16, 2	2004-03-16
3- (2,4-dimethylthiazol-5-yl) indeno [1,2-c]pyrazol-4-one derivatives and their uses App 20020107274 - Yue, Eddy W.	2002-08-08
Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use App 20020103133 - Copeland, Robert A. ; et al.	2002-08-01
Indeno [1,2-c] pyrazol-4-ones and their uses Grant 6,407,103 - Nugiel , et al. June 18, 2	2002-06-18
Indeno [1,2-c]pyrazol-4-ones and their uses App 20010027195 - Nugiel, David A. ; et al.	2001-10-04
Acylsemicarbazides and their uses Grant 6,291,504 - Nugiel , et al. September 18, 2	2001-09-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.